Neuroimmune Foundation is a 501(c)(3) non-profit organization dedicated to
  • dramatically accelerating physician education of immunopsychiatric conditions
  • significantly improving outcomes for individuals impacted by these disorders through prompt diagnosis and insurance based care
  • providing meaningful support to families during their darkest days
  • catalyzing research at an unprecedented pace that will ultimately lead to lasting remission for all individuals impacted by these disorders.
Join us for a two day conference via webinar!

Inflamma­tory Brain Disorders Conference 2025

The 2025 Inflammatory Brain Disorders Conference is hosted by Neuroimmune Institute, in partnership with Neuroimmune Foundation and with our Stanford and UCSF collaborators. Neuroimmune Institute was founded with the goal of rapidly advancing clinical medicine and research focused on immunopsychiatric, neuroimmune, and inflammatory brain conditions as well as autism.

Neuroimmune Institute offers continuing medical education on a broad array of topics beyond the scope of Neuroimmune Foundation’s mission.

New CME opportunity

Psychiatric Presentations with a Neuroimmune Basis ECHO

The Inflammatory Brain Disorders Conference features nationally and internationally renowned experts skilled in diagnostic and therapeutic approaches who will present a diverse range of emerging clinical and research challenges, insights, and advances in the field of inflammatory brain disorders. Presentations are carefully selected to familiarize attendees with rapidly developing research and to educate clinicians on the latest understanding of treatment options.

What are Inflammatory Brain Disorders?

Individuals with inflammatory brain conditions often present with prominent neuropsychiatric symptoms that can be confusing for physicians and families alike. Our CME events feature nationally and internationally renowned experts skilled in diagnostic and therapeutic approaches who present a diverse range of emerging clinical and research challenges, insights, and advances in the field of inflammatory brain disorders. Presentations are carefully selected to familiarize attendees with rapidly developing research and to educate clinicians on the latest understanding of treatment options.

Check out our

Extensive Free Resources

Our extensive free resources for clinicians include Continuing Medical Education, access to top experts in the field through monthly case consultations, and quarterly compilation of relevant research. We provide clinicians the tools to confidently diagnose and treat immune-mediated neuropsychiatric illnesses and inflammatory brain conditions. Our Circle of Clinicians helps families to find a physician. Families are supported through therapist, physician, and researcher led webinars, local support meetings in locations around the world, a private Facebook group, and other resources.

Advocating on Behalf of Individuals with Neuroimmune and Inflammatory Brain Conditions

About us

Neuroimmune FoundationTogether with our supporters, Neuroimmune Foundation is making huge strides in educating clinicians on how to diagnose and treat immune and inflammation driven causes of psychiatric deteriorations. Visit our Impact Report pages to learn how our CME and related events help physicians gain confidence treating PANS, PANDAS, encephalitis, and related conditions.

Sign up for our newsletter

  • (All fields required)

Research Roundup

  • Naproxen Adjunct to Fluoxetine for Moderate-to-severe Obsessive-compulsive Disorder: A Randomized, Double-blind, Placebo-controlled Trial

    Psychiatry and Clinical Neurosciences / Wiley
    October 1, 2024

  • IVIG Response in Pediatric Acute-onset Neuropsychiatric Syndrome Correlates with Reduction in Pro-inflammatory Monocytes and Neuropsychiatric Measures

    Frontiers in Immunology
    October 3, 2024

  • Strep Throat and the Backstory for PANS and PANDAS

    JAMA Network
    July 30, 2024

  • Development of Autoimmune Diseases Among Children With Pediatric Acute-Onset Neuropsychiatric Syndrome

    JAMA Network
    July 30, 2024

  • Transcobalamin Receptor Antibodies in Autoimmune Vitamin B12 Central Deficiency

    Science Translational Medicine 16
    June 26, 2024

  • Antipsychotic Medications Associated with Increased Length of Hospital Stay in Autoimmune Encephalitis and Multiple Sclerosis: A Retrospective Study

    Journal of Clinical Neuroscience 124
    June 2024

  • Neurofeedback for Obsessive Compulsive Disorder: A Randomized, Double-blind Trial

    Psychiatry Research 328
    October 2023

  • Anti–SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric Symptoms

    JAMA Neurology
    October 25, 2021

  • Absence of Neuronal Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus

    Annals of Neurology 88 (6)
    September 19, 2020